Bruush Oral Care Inc. Common Stock
BRSH
BRSH was delisted on the 27th of June, 2024.
2 hedge funds and large institutions have $1.77K invested in Bruush Oral Care Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 8 closing their positions.
80% less funds holding
Funds holding: 10 → 2 (-8)
97% less capital invested
Capital invested by funds: $67.4K → $1.77K (-$65.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$673 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$23.4K |
| 2 |
Renaissance Technologies
New York
|
-$19K |
| 3 |
HF
HRT Financial
New York
|
-$14K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.54K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.17K |
BRSH Hedge Fund Activity: Q2 2024 in Review
2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bruush Oral Care Inc. Common Stock (BRSH) for Q2 2024, worth a combined $1.77K — down 97% from $67.4K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BRSH and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was XTX Topco, adding an estimated $673. The largest seller was Citadel Advisors, exiting entirely with an estimated $23.4K sold.
- 2 institutional investors held Bruush Oral Care Inc. Common Stock (BRSH) as of Q2 2024, down from 10 in Q1 2024.
- Funds reported $1.77K of Bruush Oral Care Inc. Common Stock stock for Q2 2024, down 97% quarter-over-quarter.
- 0 funds opened new Bruush Oral Care Inc. Common Stock positions in Q2 2024 and 8 closed out, a net change of -8 holders.
- The largest Bruush Oral Care Inc. Common Stock buyer in Q2 2024 was XTX Topco, an estimated $673 added.
- The largest Bruush Oral Care Inc. Common Stock seller in Q2 2024 was Citadel Advisors, an estimated $23.4K sold.
Based on aggregated 13F filings for Q2 2024.